title: Detection of clinically significant QTc prolongation in phase I studies in healthy participants: comparison of 2 semiautomated QT measurement methods.
authors.affiliation: Daiichi Sankyo Pharma Development, Edison, New Jersey, USA. nsarapa@its.jnj.com
authors.forename: Nenad
authors.initials: N
authors.lastname: Sarapa
authors.forename: Steven F
authors.initials: SF
authors.lastname: Francom
authors.forename: Sara M
authors.initials: SM
authors.lastname: Azzam
authors.forename: Prachi K
authors.initials: PK
authors.lastname: Wickremasingha
authors.forename: Benoit
authors.initials: B
authors.lastname: Tyl
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004311:Double-Blind Method; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines / Q000009:adverse effects*; D015363:Quinolones / Q000009:adverse effects*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; C505440:DX 619; D011759:Pyrrolidines; D015363:Quinolones